Literature DB >> 26622693

Radiosensitivity in HeLa cervical cancer cells overexpressing glutathione S-transferase π 1.

Liang Yang1, Ren Liu2, Hong-Bin Ma3, Ming-Zhen Ying1, Ya-Jie Wang1.   

Abstract

The aims of the present study were to investigate the effect of overexpressed exogenous glutathione S-transferase π 1 (GSTP1) gene on the radiosensitivity of the HeLa human cervical cancer cell line and conduct a preliminarily investigation into the underlying mechanisms of the effect. The full-length sequence of human GSTP1 was obtained by performing a polymerase chain reaction (PCR) using primers based on the GenBank sequence of GSTP1. Subsequently, the gene was cloned into a recombinant eukaryotic expression plasmid, and the resulting construct was confirmed by restriction analysis and DNA sequencing. A HeLa cell line that was stably expressing high levels of GSTP1 was obtained through stable transfection of the constructed plasmids using lipofectamine and screening for G418 resistance, as demonstrated by reverse transcription-PCR. Using the transfected HeLa cells, a colony formation assay was conducted to detect the influence of GSTP1 overexpression on the cell radiosensitivity. Furthermore, flow cytometry was used to investigate the effect of GSTP1 overexpression on cell cycle progression, with the protein expression levels of the cell cycle regulating factor cyclin B1 detected using western blot analysis. Colony formation and G2/M phase arrest in the GSTP1-expressing cells were significantly increased compared with the control group (P<0.01). In addition, the expression of cyclin B1 was significantly reduced in the GSTP1-expressing cells. These results demonstrated that increased expression of GSTP1 inhibits radiosensitivity in HeLa cells. The mechanism underlying this effect may be associated with the ability of the GSTP1 protein to reduce cyclin B1 expression, resulting in significant G2/M phase arrest.

Entities:  

Keywords:  cell cycle; glutathione S-transferase π 1; human cervical cancer; radiosensitivity

Year:  2015        PMID: 26622693      PMCID: PMC4533307          DOI: 10.3892/ol.2015.3394

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

Review 1.  Epidermal growth factor family receptors and inhibitors: radiation response modulators.

Authors:  Carolyn I Sartor
Journal:  Semin Radiat Oncol       Date:  2003-01       Impact factor: 5.934

2.  Synthesis and structure--activity relationship of new cytotoxic agents targeting human glutathione-S-transferases.

Authors:  Dante Rotili; Anastasia De Luca; Domenico Tarantino; Silvia Pezzola; Mariantonietta Forgione; Blasco Morozzo Della Rocca; Mattia Falconi; Antonello Mai; Anna Maria Caccuri
Journal:  Eur J Med Chem       Date:  2014-10-13       Impact factor: 6.514

3.  Effect of miR-18a overexpression on the radiosensitivity of non-small cell lung cancer.

Authors:  Zetian Shen; Xinhu Wu; Zhen Wang; Bing Li; Xixu Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  The role of glutathione-S-transferase polymorphisms in ovarian cancer survival.

Authors:  Christina M Nagle; Georgia Chenevix-Trench; Amanda B Spurdle; Penelope M Webb
Journal:  Eur J Cancer       Date:  2006-11-03       Impact factor: 9.162

5.  Green synthesis of platinum nanoparticles that induce cell death and G2/M-phase cell cycle arrest in human cervical cancer cells.

Authors:  Ali A Alshatwi; Jegan Athinarayanan; Periasamy Vaiyapuri Subbarayan
Journal:  J Mater Sci Mater Med       Date:  2015-01-11       Impact factor: 3.896

6.  Kinetic Models for Predicting Cervical Cancer Response to Radiation Therapy on Individual Basis Using Tumor Regression Measured In Vivo With Volumetric Imaging.

Authors:  Antonella Belfatto; Marco Riboldi; Delia Ciardo; Federica Cattani; Agnese Cecconi; Roberta Lazzari; Barbara Alicja Jereczek-Fossa; Roberto Orecchia; Guido Baroni; Pietro Cerveri
Journal:  Technol Cancer Res Treat       Date:  2015-03-10

Review 7.  New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.

Authors:  M von Knebel Doeberitz
Journal:  Eur J Cancer       Date:  2002-11       Impact factor: 9.162

8.  Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.

Authors:  Gerald Zon; Melissa A Barker; Pavinder Kaur; Susan Groshen; Lawrence W Jones; S Ashraf Imam; Victoria L Boyd
Journal:  Anal Biochem       Date:  2009-06-06       Impact factor: 3.365

9.  Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.

Authors:  Wei Wang; Guangxian Liu; Jiang Zheng
Journal:  Eur J Pharmacol       Date:  2007-04-22       Impact factor: 4.432

Review 10.  Hypertension in patients with cancer.

Authors:  Vinicius Barbosa de Souza; Eduardo Nani Silva; Mario Luiz Ribeiro; Wolney de Andrade Martins
Journal:  Arq Bras Cardiol       Date:  2015-02-27       Impact factor: 2.000

View more
  2 in total

1.  Dimethylfumarate induces cell cycle arrest and apoptosis via regulating intracellular redox systems in HeLa cells.

Authors:  Guocan Han; Qiang Zhou
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-08-05       Impact factor: 2.416

2.  FBX8 degrades GSTP1 through ubiquitination to suppress colorectal cancer progression.

Authors:  Wang FeiFei; Xu HongHai; Yan YongRong; Wu PingXiang; Wu JianHua; Zhu XiaoHui; Li JiaoYing; Sun JingBo; Zhou Kun; Ren XiaoLi; Qi Lu; Lan XiaoLiang; Cheng ZhiQiang; Tang Na; Liao WenTing; Ding YanQing; Liang Li
Journal:  Cell Death Dis       Date:  2019-04-25       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.